BioHomex, UAB - company info and details

Company age: 4 y. 2 mo.

Update

Company overview

Company name BioHomex, UAB
Company code 306139255
VAT code LT100016599415
Registered address Vilnius, A. Goštauto g. 8-109, LT-01108
Registration date 2022-08-31 Company age: 4 y. 2 mo.
Phone Phone
Email Email
Website None
Revenue (2025) 38,613 € +707% History
Profit (2025) -129 € History
Share capital 14,000 €
Number of employees 2 History
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt 286 € From: 2026-07-30 Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity Other cleaning activities
Ownership form Private without foreign capital

Description

This description was generated by artificial intelligence.
BioHomex, UAB (company code 306139255) is an operational private limited liability company registered on 31 August 2022. It is a micro-sized business in the sector of national private non-financial companies, operating under private ownership with more than 50% of authorised capital held by Lithuanian natural and legal persons and no foreign investor capital. The company is governed by a CEO only. Its registered office is in Vilnius, A. Goštauto g. 8-109, Vilniaus m. sav., Vilniaus apskr. The company’s main activity is O.81.23.00, Other cleaning activities.

In its latest available financial year in the dataset, 2024, BioHomex generated revenue of €4.8K, compared with €745 in 2023, but still recorded a net loss of €8.8K and a profit margin of -183.5%. Equity stood at €5.2K at the end of 2024, with liabilities of €22.6K and total assets of €27.9K. The share capital is €14.0K. Staffing levels have been small and variable: the company averaged 1 employee in 2023, 5 in 2024, 3 in 2025, and so far in 2026 it has averaged 1 employee. The average monthly wage was €413.45 in 2025.

Download a detailed company report

Make confident decisions with all the information about BioHomex, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report